142 related articles for article (PubMed ID: 9122966)
1. Hypertension in patients after renal transplantation.
Budde K; Waiser J; Fritsche L; Zitzmann J; Schreiber M; Kunz R; Neumayer HH
Transplant Proc; 1997; 29(1-2):209-11. PubMed ID: 9122966
[No Abstract] [Full Text] [Related]
2. Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.
Martínez-Castelao A; Hueso M; Sanz V; Rejas J; Sarrias J; Alsina J; Grinyó JM
Transplant Proc; 2002 Feb; 34(1):403-6. PubMed ID: 11959345
[No Abstract] [Full Text] [Related]
3. Cyclosporine trough levels in diabetic and nondiabetic renal transplant patients.
Wadhawan S; Jauhari H; Singh S
Transplant Proc; 2000 Nov; 32(7):1683-4. PubMed ID: 11119891
[No Abstract] [Full Text] [Related]
4. Hypertension in renal transplant recipients and its effect on long-term renal allograft survival.
Kokado Y; Takahara S; Kameoka H; Okuyama A
Transplant Proc; 1996 Jun; 28(3):1600-2. PubMed ID: 8658802
[No Abstract] [Full Text] [Related]
5. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral.
Vathsala A; Lee WT; Jacob E; Woo KT
Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678
[No Abstract] [Full Text] [Related]
6. Reduction in blood cyclosporine concentration by orlistat in two renal transplant patients.
Errasti P; García I; Lavilla J; Ballester B; Manrique J; Purroy A
Transplant Proc; 2002 Feb; 34(1):137-9. PubMed ID: 11959223
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of losartan in renal transplant recipients.
Hadjigavriel M; Kyriakides G
Transplant Proc; 1999 Dec; 31(8):3300-1. PubMed ID: 10616484
[No Abstract] [Full Text] [Related]
8. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
Cossu M; Satta R; Branca GF; Pala PG; Serra G; Satta RP; Sorba G
Transplant Proc; 1998 Aug; 30(5):1762-3. PubMed ID: 9723271
[No Abstract] [Full Text] [Related]
9. Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
Nakache R; Weinbroum A; Merhav H; Katz P; Kaplan E
Transplant Proc; 2001 May; 33(3):2294-5. PubMed ID: 11377533
[No Abstract] [Full Text] [Related]
10. Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant.
Rial MC; Frias S; Argento J; Tessler J; Casadei D
Transplant Proc; 1997; 29(1-2):292-3. PubMed ID: 9123001
[No Abstract] [Full Text] [Related]
11. Chronic renal allograft dysfunction: immunologic and nonimmunologic risk factors.
Golbabaie M; Kayedi M; Najafi I; Ganji MR; Naderi GH; Mehraban D; Hakemi M
Transplant Proc; 2001 Aug; 33(5):2691-2. PubMed ID: 11498126
[No Abstract] [Full Text] [Related]
12. Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.
Wilczek HE; Akesson P; Warholm C
Transplant Proc; 1998 Aug; 30(5):1753-5. PubMed ID: 9723267
[No Abstract] [Full Text] [Related]
13. Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
Griffin PJ; Moore RH; Jurewicz WA; Lord RH; Webley Y; Jenkins J
Transplant Proc; 1997; 29(1-2):303. PubMed ID: 9123007
[No Abstract] [Full Text] [Related]
14. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
Løkkegaard H; Asmundsson P; Clausen P; Dieperink H; Hansen JM; Heaf J; Jensen SB; Kornerup HJ; Madsen S; Pedersen EB; Poulsen JV; Rasmussen K
Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
[No Abstract] [Full Text] [Related]
15. Evaluation of the new cyclosporine formulation, Consupren, in renal transplant patients.
Stephan AG; Barbari A; Masri MA; Rizk S; Moubarak R; Frem GJ; Kamel G; Baracat-Khoury W; Karam A
Transplant Proc; 1996 Jun; 28(3):1348-9. PubMed ID: 8658688
[No Abstract] [Full Text] [Related]
16. Conventional versus Neoral cyclosporine in renal transplantation.
Rovelli E; Bucci A; Maldifassi P; Belfiore A; D'Amico G
Transplant Proc; 1998 Aug; 30(5):1764-5. PubMed ID: 9723272
[No Abstract] [Full Text] [Related]
17. Systemic hypertension and renal function in long-term liver transplant recipients on cyclosporine.
Semhoun-Ducloux S; Ducloux D; Bresson-Hadni S; Becker M; Vanlemmens C; Mantion G; Chalopin J; Miguet J
Transplant Proc; 2000 Mar; 32(2):449-52. PubMed ID: 10715476
[No Abstract] [Full Text] [Related]
18. Effect of variability of cyclosporine pharmacokinetics on long-term renal allograft survival.
Markell MS; Homel P; Sumrani N; Hong JH; Distant DA; Miles AM; Sommer BG; Friedman EA
Transplant Proc; 1998 Aug; 30(5):1980-2. PubMed ID: 9723360
[No Abstract] [Full Text] [Related]
19. Low exposure to cyclosporine is a risk factor for the occurrence of chronic rejection after kidney transplantation.
Citterio F; Torricelli P; Serino F; Foco M; Pozzetto U; Fioravanti P; Castagneto M
Transplant Proc; 1998 Aug; 30(5):1688-90. PubMed ID: 9723245
[No Abstract] [Full Text] [Related]
20. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
Małyszko J; Małyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3069-72. PubMed ID: 19857679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
